0001628280-26-034101
SEC filingSkinHealth Systems Inc. received Nasdaq notice of non-compliance with $1.00 minimum bid price rule, with 180 days until November 4, 2026, to regain compliance or face potential delisting.
The Beauty Health Company, operating as SkinHealth Systems Inc., faces a critical compliance challenge with Nasdaq Listing Rule 5550(a)(2) due to its Class A Common Stock's closing bid price remaining below $1.00 for 30 consecutive business days. This notification triggers a 180-day grace period ending November 4, 2026, during which the company must sustain a $1.00+ closing price for at least ten consecutive business days—potentially extended to twenty at Nasdaq's discretion. Failure to comply opens eligibility for a second 180-day extension, contingent on satisfying all other Nasdaq Capital Market standards, including market value of publicly held shares, and notifying Nasdaq of cure plans like a reverse stock split. Investors should note the heightened delisting risk if deficiencies persist, with an appeal process available via Nasdaq Hearings Panel. The company's proactive monitoring and consideration of options underscore urgency, but forward-looking statements highlight substantial uncertainties tied to stock price recovery and broader listing adherence.